SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    P. M. Meiners, A. Vissink, F. G. M. Kroese, F. K. L. Spijkervet, N. S. Smitt-Kamminga, W. H. Abdulahad, J. Bulthuis-Kuiper, E. Brouwer, S. Arends, H. Bootsma, Abatacept treatment reduces disease activity in early primary Sjogren's syndrome (open-label proof of concept ASAP study), Annals of the Rheumatic Diseases, 2014, 73, 7, 1393

    CrossRef

  2. 2
    Pilar Brito-Zerón, Manuel Ramos-Casals, Advances in the understanding and treatment of systemic complications in Sjögrenʼs syndrome, Current Opinion in Rheumatology, 2014, 26, 5, 520

    CrossRef

  3. 3
    Frans G.M. Kroese, Dominique Baeten, Tom W.J. Huizinga, Autoimmunity: Break-through in the diagnosis and treatment of immune-mediated inflammatory diseases, Immunology Letters, 2014,

    CrossRef

  4. 4
    P. R. Sada, D. Isenberg, C. Ciurtin, Biologic treatment in SS, Rheumatology, 2014,

    CrossRef

  5. 5
    Valéria Valim, Virginia Fernandes Moça Trevisani, Jacqueline Martins de Sousa, Verônica Silva Vilela, Rubens Belfort, Current Approach to Dry Eye Disease, Clinical Reviews in Allergy & Immunology, 2014,

    CrossRef

  6. 6
    Hiroto Tsuboi, Isao Matsumoto, Shinya Hagiwara, Tomoya Hirota, Hiroyuki Takahashi, Hiroshi Ebe, Masahiro Yokosawa, Chihiro Hagiya, Hiromitsu Asashima, Chinatsu Takai, Haruka Miki, Naoto Umeda, Yuya Kondo, Hiroshi Ogishima, Takeshi Suzuki, Shintaro Hirata, Kazuyoshi Saito, Yoshiya Tanaka, Yoshiro Horai, Hideki Nakamura, Atsushi Kawakami, Takayuki Sumida, Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: Rheumatoid Arthritis with Orencia Trial toward Sjögren's syndrome Endocrinopathy (ROSE) trial—an open-label, one-year, prospective study—Interim analysis of 32 patients for 24 weeks, Modern Rheumatology, 2014, 1

    CrossRef

  7. 7
    Francisco J. Llamas-Gutierrez, Edgardo Reyes, Braulio Martínez, Gabriela Hernández-Molina, Histopathological environment besides the focus score in Sjögren's syndrome, International Journal of Rheumatic Diseases, 2014, 17, 6
  8. 8
    Haralampos M. Moutsopoulos, Sjögren's syndrome: A forty-year scientific journey, Journal of Autoimmunity, 2014, 51, 1

    CrossRef

  9. 9
    Divi Cornec, Christophe Jamin, Jacques-Olivier Pers, Sjögren's syndrome: Where do we stand, and where shall we go?, Journal of Autoimmunity, 2014, 51, 109

    CrossRef

  10. 10
    Alessia Alunno, Francesco Carubbi, Elena Bartoloni, Onelia Bistoni, Sara Caterbi, Paola Cipriani, Roberto Giacomelli, Roberto Gerli, Unmasking the pathogenic role of IL-17 axis in primary Sjögren's syndrome: A new era for therapeutic targeting?, Autoimmunity Reviews, 2014, 13, 12, 1167

    CrossRef